The 2006 EU nutrition and health claims regulation is putting the brakes on the commissioning of trials to back claims, according to Cédric Bourges-Sevenier, PhD, general manager at French science and regulatory consultancy, Nutraveris.
The manner in which pre-menstrual and menopausal indications for soy and red clover isoflavones that recently won approval from the European Patent Office can be translated into marketing messages, is being debated among soy players.
The European Food Safety Authority (EFSA) has rejected three article 13.5 probiotic and prebiotic health claims and one article 14 claim linking prebiotics with a range of benefits from immunity to diarrhoea for failing to demonstrate causality.
The pressure is mounting for formal discussions between industry and the European Commission and the European Food Safety Authority (EFSA) on more than 4000 generic health claim submissions, with the CIAA urging immediate dialogue.
A group of prominent lipid scientists has petitioned the EU calling for a rethink of draft daily reference intake levels for omega-3s they fear will only confuse consumers and disadvantage marine-sourced omega-3 suppliers.
The European Food Safety Authority (EFSA) and European Commission have acknowledged for the first time that the July 31 deadline for publication of the first batch of health claim opinions will not be met.